3 hours ago • onclive.com
Dr Isaacs on Establishing Consensus on DESTINY-Breast09 Data in HER2+ Metastatic Breast Cancer
3 hours ago • onclive.com
Dr Isaacs on Establishing Consensus on DESTINY-Breast09 Data in HER2+ Metastatic Breast Cancer3 hours ago • onclive.com
Ongoing Trials Aim to Remove Carboplatin from TCHP and Reduce Treatment Cycles in HER2+ Breast Cancer2025-06-25 • biospace.com
OS Therapies Receives Positive FDA Meeting Feedback on Regulatory Pathway for Accelerated Approval of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma2025-06-22 • geneonline.com
Phase 3 Trial Shows Vepdegestrant Outperforms Fulvestrant in ER+/HER2- Advanced Breast Cancer Treatment2025-06-21 • geneonline.com
Vepdegestrant Outperforms Fulvestrant in Phase 3 Trial for ER+/HER2- Advanced Breast Cancer2025-06-20 • prnewswire.co.uk
HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During the Study Period (2020-2034) | DelveInsight2025-06-19 • rarecancernews.com
1st patient dosed in trial of Enhertu for HER2 endometrial cancer2025-06-18 • newswire.ca
Health Canada approves Novartis' KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence2025-06-12 • onclive.com
DESTINY-Breast09 and Ongoing Trials Underscore Shifting ADC Landscape in HER2+ Breast Cancer2025-06-12 • oncnursingnews.com
T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations2025-06-10 • onclive.com
OS Therapies Seeks RMAT Designation for OST-HER2 in Pediatric Lung-Metastatic Osteosarcoma2025-06-10 • PR Newswire
OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma2025-06-10 • prnewswire.co.uk
HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020-2034) | DelveInsight2025-06-06 • onclive.com
Dr Tolaney on the Clinical Implications of First-Line T-DXd Plus Pertuzumab in HER2+ Breast Cancer2025-06-06 • oncologynewscentral.com
Drug Combo Sets New PFS Benchmark in HER2-Positive Breast Cancer2025-06-05 • investingnews.com
Radiopharm Theranostics Doses First Patient in Phase 1 'HEAT' Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors2025-06-05 • EIN Presswire
Comprehensive Insights Of The Global HER2 Inhibitors Market: Key Drivers, Trends, Growth, And Forecast For 2025-20342025-06-03 • biospace.com
ENHERTU® Reduced the Risk of Death by 30% Versus Ramucirumab Plus Paclitaxel as a Second-Line Therapy in Patients with HER2 Positive Unresectable or Metastatic Gastric Cancer in DESTINY-Gastric04 Phase 3 Trial2025-06-03 • PR Newswire
Alphamab Oncology Presented Multiple Clinical Data of Anti-HER2 Biparatopic ADC JSKN003 at the 2025 ASCO Annual Meeting2025-06-03 • PR Newswire
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors2025-06-03 • PR Newswire
2025 ASCO ｜Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer2025-06-02 • PR Newswire
Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera® (zanidatamab-hrii) in First-Line HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ASCO 20252025-06-01 • ascopost.com
Trastuzumab Deruxtecan Improves Survival Outcomes in Patients With HER2-Positive Gastric/GEJ Cancer in Second-Line Setting2025-06-01 • globenewswire.com
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer2025-05-31 • onclive.com
Zanidatamab Wins Approval in China for Previously Treated, HER2+ Biliary Tract Cancer2025-05-30 • onclive.com
Dr Bardia on Efficacy Data from the DESTINY-Breast06 Trial of T-DXd in HER2-Low/-Ultralow Metastatic Breast Cancer2025-05-29 • onclive.com
Clinical Insights Into Managing Heavily Pretreated HER2+ Metastatic Breast Cancer2025-05-29 • PR Newswire
China's HER2-Targeted ADC Trastuzumab Rezetecan Gains NMPA Approval for HER2-Mutant NSCLCJust now • marketbeat.com
Promising Cloud Storage Stocks To Keep An Eye On - June 25thJust now • naturalgasintel.com
Freeport LNG Requests Additional Time for Train 4 Expansion ProjectJust now • investing.com
Schroder European Real Estate Declares 00148 Per Share DividendJust now • vallartadaily.com
Jalisco unveils major infrastructure and tourism plans ahead of 2026 World CupJust now • dynamitenews.com
Jindal Steel hailed as ‘Champion of Green Business Practices’ by ET Edge for environment commitmentJust now • ahmedabadmirror.com
Digital mapping of sewer lines, manholes on cards1 minute ago • digitimes.com
Taiwan chipmakers' caution on India's semiconductor ambitions heightens after Aptos collapse1 minute ago • defensemirror.com
China to Debut New Combat Forces at September 9 Military Parade1 minute ago • energetica-india.net
GameChange Solar Launches 8 Projects Totaling 715 MWp in Latin America1 minute ago • propnewstime.com
AVP Infracon wins INR 33.34 crore contract for Reliance Mappedu logistics park2 minutes ago • newswire.ca
Hearing Notice - IN THE MATTER OF Ronald Aleri Scott - Adjournment2 minutes ago • netimes.com.au
Tamworth High to gain expanded gifted education programJust now • naturalgasintel.com
Freeport LNG Requests Additional Time for Train 4 Expansion ProjectJust now • desmog.com
Louisiana’s New Bill Would Codify Gas as ‘Green Energy’Just now • marketbeat.com
Promising Cloud Storage Stocks To Keep An Eye On - June 25th2025-06-26 • binance.com
Moscow Exchange Plans New Bitcoin Index Futures And Crypto Funds2025-06-26 • tradingview.com
Russia's May industrial output rises 1.8% y/y2025-06-26 • energyandcleanair.org
Russia’s LNG workaround and tapping into the West’s leverageJust now • bwpeople.in
Raymond Realty Names New Board Ahead Of Market DebutJust now • dynamitenews.com
Jindal Steel hailed as ‘Champion of Green Business Practices’ by ET Edge for environment commitmentJust now • ahmedabadmirror.com
Digital mapping of sewer lines, manholes on cardsJust now • investing.com
Schroder European Real Estate Declares 00148 Per Share Dividend1 minute ago • logisticsmanager.com
UK Trade Strategy signals digital and supply chain reset for exporters and logistics sector2 minutes ago • countypress.co.uk
Ryde transport hub upgrade has earned national recognitionStay ahead with real-time headlines from top sources, categorized by sector and country.